| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1359-6101(03)00003-0 |
| P698 | PubMed publication ID | 12651220 |
| P2093 | author name string | Sharon M Wahl | |
| WanJun Chen | |||
| P2860 | cites work | TGF-beta signal transduction | Q22003891 |
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells | Q28203889 | ||
| TGF-beta: receptors, signaling pathways and autoimmunity | Q28217375 | ||
| Maternal rescue of transforming growth factor-beta 1 null mice | Q28511932 | ||
| Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| The ever-increasing complexity of TGF-beta signaling | Q31032888 | ||
| Regulatory T cells: key controllers of immunologic self-tolerance | Q33941140 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice | Q34527377 | ||
| Transforming growth factor-beta in T-cell biology | Q34572232 | ||
| Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth | Q36351780 | ||
| Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc | Q36367920 | ||
| Certified professionals: CD4(+)CD25(+) suppressor T cells | Q36369181 | ||
| Requirement for transforming growth factor beta1 in controlling T cell apoptosis | Q36369531 | ||
| The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease | Q36370178 | ||
| CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness | Q36370807 | ||
| Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells | Q36401309 | ||
| TGF-beta: 20 years and counting. | Q53534770 | ||
| Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells | Q56905940 | ||
| TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar | Q56906232 | ||
| IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 | ||
| TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu | Q74070676 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| P433 | issue | 2 | |
| P921 | main subject | immunosuppression | Q1455316 |
| P304 | page(s) | 85-89 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Cytokine and Growth Factor Reviews | Q15763303 |
| P1476 | title | TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression | |
| P478 | volume | 14 |
| Q34625152 | A cytokine-mediated link between innate immunity, inflammation, and cancer |
| Q34365057 | A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles |
| Q34695479 | A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta |
| Q33412876 | Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). |
| Q35600811 | Altering immune tolerance therapeutically: the power of negative thinking |
| Q41815808 | Apoptotic cell-linked immunoregulation: implications for promoting immune tolerance in transplantation |
| Q33637647 | Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells |
| Q34624101 | CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients |
| Q91069783 | CD4+CD25+ Tregs as dependent factor in the course of bleomycin-induced pulmonary fibrosis in mice |
| Q44643759 | CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. |
| Q37017450 | CD5 plays an inhibitory role in the suppressive function of murine CD4(+) CD25(+) T(reg) cells |
| Q56898701 | CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis |
| Q92088390 | Combination of apoptotic T cell induction and self-peptide administration for therapy of experimental autoimmune encephalomyelitis |
| Q24672849 | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 |
| Q39102545 | Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma. |
| Q24804229 | Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma |
| Q37771941 | Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection |
| Q46468450 | Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function |
| Q85026478 | Down-regulation of Treg cells and up-regulation of TH1/TH2 cytokine ratio were induced by polysaccharide from Radix Glycyrrhizae in H22 hepatocarcinoma bearing mice |
| Q33837770 | Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis |
| Q34775608 | Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction |
| Q44703963 | Elevation of plasma transforming growth factor beta1 levels in stable nonatopic asthma |
| Q35998238 | Engineering an "infectious" T(reg) biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces |
| Q37937127 | FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance |
| Q37195009 | Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells |
| Q38201272 | Harnessing FOXP3+ regulatory T cells for transplantation tolerance. |
| Q54568607 | How many mechanisms do regulatory T cells need? |
| Q36327386 | Immunomodulatory strategies for celiac disease |
| Q39019244 | Immunoregulation by members of the TGFβ superfamily |
| Q36162929 | Immunotherapy of malignant brain tumors |
| Q91737517 | Improved therapeutic potential of MSCs by genetic modification |
| Q36403942 | Inactivation of c-Cbl reverses neonatal lethality and T cell developmental arrest of SLP-76-deficient mice |
| Q34770407 | Inflammatory manifestations of experimental lymphatic insufficiency |
| Q40436147 | Intracisternal administration of transforming growth factor-beta evokes fever through the induction of cyclooxygenase-2 in brain endothelial cells |
| Q54621895 | Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. |
| Q51824843 | Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen. |
| Q27014375 | Lung cancer vaccines |
| Q36110782 | Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis |
| Q37209541 | Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis |
| Q41808459 | Mechanisms of local immunosuppression in cutaneous melanoma. |
| Q33617746 | Mechanisms of self-nonself discrimination and possible clinical relevance |
| Q34971545 | PARP-1 controls immunosuppressive function of regulatory T cells by destabilizing Foxp3 |
| Q34381920 | Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids |
| Q36750481 | Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors |
| Q36378338 | Regulating immunity to malaria |
| Q38622693 | Regulatory T cells in cardiovascular diseases |
| Q37349918 | Regulatory T cells in renal disease |
| Q41862600 | Regulatory T cells use "Itch" to control asthma |
| Q39466907 | Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice |
| Q92042963 | Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer |
| Q36738543 | Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance |
| Q37815442 | Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes? |
| Q90281573 | Smad7 Controls Immunoregulatory PDL2/1-PD1 Signaling in Intestinal Inflammation and Autoimmunity |
| Q26738584 | Stabilization of high-risk plaques |
| Q34787928 | Subconjunctivally applied naïve Tregs support corneal graft survival in baby rats |
| Q37224027 | Subpopulations of bovine WC1(+) gammadelta T cells rather than CD4(+)CD25(high) Foxp3(+) T cells act as immune regulatory cells ex vivo |
| Q36251293 | T cell tolerance induced by therapeutic antibodies |
| Q36997273 | T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology |
| Q33999342 | TGF-beta and 'adaptive' Foxp3(+) regulatory T cells |
| Q36893657 | TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. |
| Q36020084 | TGF-beta and tumors--an ill-fated alliance |
| Q36187040 | TGF-beta inhibitors for the treatment of cancer |
| Q37358159 | TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes |
| Q35628232 | TGF-beta, T-cell tolerance and anti-CD3 therapy |
| Q28263622 | TGF-beta: a mobile purveyor of immune privilege |
| Q35624700 | TGF-beta: how tolerant can it be? |
| Q35668744 | TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells |
| Q34276027 | TGFβ in T cell biology and tumor immunity: Angel or devil? |
| Q36326572 | Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality |
| Q61798430 | Th17/Treg imbalance in COPD progression: A temporal analysis using a CS-induced model |
| Q33608606 | The Treg/Th17 paradigm in lung cancer |
| Q56902043 | The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children |
| Q37959968 | The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance |
| Q37738676 | The role of regulatory T cells in respiratory infections and allergy and asthma. |
| Q35547512 | The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets |
| Q34982303 | Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice. |
| Q36981811 | Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17 |
| Q40476384 | Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. |
| Q24804340 | Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases |
| Q37633528 | Transforming growth factor-beta: a target for cancer therapy |
| Q36557587 | Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance |
| Q39346505 | Transforming growth factor-β: A therapeutic target for cancer |
| Q56474910 | Tregs in immunotherapy: opportunities and challenges |
| Q30743356 | Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1. |
| Q36516410 | Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer |
| Q37848203 | Tumour-associated antigens: considerations for their use in tumour immunotherapy. |
| Q35842612 | Using antibodies in tumour immunotherapy |
Search more.